Skip to main content
Back to Investors

Parkwalk Advisors Portfolio Companies

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

Last updated: July 2026

Parkwalk Advisors Investment Overview

Portfolio Companies
144
Total Invested
$1.1B
Average Investment
$12.7M

Parkwalk Advisors's Most Recent Investments (2020+)

Company NameFoundedFunding StageAmountCity
NoBACZ2025Series Unknown$6.4MCambridge
Trismik2025Pre-Seed$3.0MCambridge
Enhanc3D Genomics2025Series A$5.4MCambridge
Xampla2025Series A$14.0MCambridge
Paragraf2025Series C$55.0MSomersham
Bitfount2025Series A$8.0MLondon
Zentraxa2025SeedUndisclosedBristol
Psyomics2025Non Equity AssistanceUndisclosedCambridge
OSSTEC2025Seed$3.2MLondon
Cambridge Electric Cement2025Non Equity AssistanceUndisclosedCambridge

Complete List of Parkwalk Advisors Portfolio Companies (144)

Export
#CompanyStageAmountLocation
76NoBACZSeries Unknown$6.4MCambridge, United Kingdom
77TrismikPre-Seed$3.0MCambridge, United Kingdom
78Enhanc3D GenomicsSeries A$5.4MCambridge, United Kingdom
79XamplaSeries A$14.0MCambridge, United Kingdom
80ParagrafSeries C$55.0MSomersham, United Kingdom
81BitfountSeries A$8.0MLondon, United Kingdom
82ZentraxaSeedUndisclosedBristol, United Kingdom
83PsyomicsNon Equity AssistanceUndisclosedCambridge, United Kingdom
84OSSTECSeed$3.2MLondon, United Kingdom
85Cambridge Electric CementNon Equity AssistanceUndisclosedCambridge, United Kingdom
Health CareManufacturingVeterinary

NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market.

Cambridge, United Kingdom
September 2025
$6.4M
Series Unknown

Founder Contacts

19,000+ verified contacts

Information TechnologySoftware

Trismik is an early-stage company specializing in efficient real-world evaluations, particularly for LLMs.

Cambridge, United Kingdom
September 2025
$3.0M
Pre-Seed

Founder Contacts

19,000+ verified contacts

Biotechnology

Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.

Cambridge, United Kingdom
September 2025
$5.4M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyCleanTechPlastics and Rubber Manufacturing

Xampla develops natural, biodegradable materials as sustainable alternatives to traditional plastics.

Cambridge, United Kingdom
September 2025
$14.0M
Series A

Founder Contacts

19,000+ verified contacts

Advanced MaterialsElectronicsIndustrial EngineeringManufacturing

Paragraf develops and manufactures graphene-based electronic devices for the sensors and diagnostics markets.

Somersham, United Kingdom
August 2025
$55.0M
Series C

Founder Contacts

19,000+ verified contacts

AnalyticsArtificial Intelligence (AI)Big DataCollaborationInformation ServicesInformation TechnologyMachine LearningSoftware

Federated data science and AI platform for privacy-preserving analytics & AI/ML

London, United Kingdom
July 2025
$8.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyTest and Measurement

Zentraxa has specialise in the design, production and testing of complex novel peptides.

Bristol, United Kingdom
May 2025
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalUniversities

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

Cambridge, United Kingdom
April 2025
Non Equity Assistance

Founder Contacts

19,000+ verified contacts

3D Printing3D TechnologyMedical

The next step forward in orthopaedics

London, United Kingdom
March 2025
$3.2M
Seed

Founder Contacts

19,000+ verified contacts

Building MaterialConstructionGreen Building

Cambridge Electric Cement is a sustainable cement start-up.

Cambridge, United Kingdom
March 2025
Non Equity Assistance

Founder Contacts

19,000+ verified contacts

ElectronicsManufacturingSemiconductor

Cambridge GaN Devices is a semiconductor company focused on developing GaN power devices aimed at creating greener electronics.

Cambridge, United Kingdom
February 2025
$32.0M
Series C

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Computer VisionIndustrialPorts and HarborsSoftware

RoboK is a computer vision startup with a mission to make all industrial workplaces safe and high-performing with AI.

Cambridge, United Kingdom
January 2025
$1.1M
Grant

Founder Contacts

19,000+ verified contacts

EnergyManufacturingRenewable Energy

Illumion developes a lab-based real-time measurement device designed to offer detailed insights into energy storage processes.

Cambridge, United Kingdom
December 2024
$2.7M
Seed

Founder Contacts

19,000+ verified contacts

Biotechnology

Abselion is the biological sensor for rapid and cost-effective detection of biological substances.

Cambridge, United Kingdom
December 2024
$8.4M
Series A

Founder Contacts

19,000+ verified contacts

BatteryEnergy StorageManufacturingRenewable Energy

Echion Technologies develops XNO anode materials designed for Li-ion batteries used in heavy-duty electric vehicles.

Cambridge, United Kingdom
November 2024
$12.6M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife Science

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.

Cambridge, United Kingdom
October 2024
$10.3M
Seed

Founder Contacts

19,000+ verified contacts

EnergyEnergy ManagementInformation Technology

Barocal is a refrigeration technology company that develops solid-state cooling and heating systems for efficient cooling.

London, United Kingdom
October 2024
$2.7M
Grant

Founder Contacts

19,000+ verified contacts

EnergyIndustrial Engineering

Cheesecake Energy is developing advanced thermal and compressed air energy systems to store energy.

Nottingham, United Kingdom
September 2024
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyRecycling

Evoralis is an enzyme development company that specializes in the discovery and development of plastic-depolymerizing enzymes.

Cambridge, United Kingdom
September 2024
$3.3M
Seed

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth Care

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Cambridge, United Kingdom
September 2024
$12.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

Oxford, United Kingdom
May 2024
$10.2M
Series A

Founder Contacts

19,000+ verified contacts

EnergyEnergy EfficiencyOil and GasSensor

Silicon MicroGravity is a company developing novel sensor technology.

Cambridge, United Kingdom
May 2024
$4.5M
Undisclosed

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical DeviceWellness

gaitQ® develops innovative wearable technology that improves people’s mobility and quality of life.

Oxford, United Kingdom
April 2024
Grant

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)CleanTechMachine LearningManufacturing

Carbon Re is a climate technology company developing artificial intelligence to decarbonize energy-intensive industries.

London, United Kingdom
March 2024
$172K
Grant

Founder Contacts

19,000+ verified contacts

Health CareMedical Device

Adsilico redefines medical device innovation.

Leeds, United Kingdom
February 2024
$4.4M
Seed

Founder Contacts

19,000+ verified contacts

Showing 76-100 of 144 portfolio companies

Frequently Asked Questions About Parkwalk Advisors

How many companies has Parkwalk Advisors invested in?

Parkwalk Advisors has invested in 144 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Parkwalk Advisors invest in?

Parkwalk Advisors's top investment sectors include Biotechnology, Health Care, Manufacturing, Medical, Energy. The firm invests across 42 different industry categories.

What is Parkwalk Advisors's largest investment?

Among tracked funding rounds, Paragraf received $55.0M in a Series C round. Parkwalk Advisors's total known invested capital is $1.1B.

What is the average investment size for Parkwalk Advisors?

Parkwalk Advisors's average investment size is $12.7M across its portfolio of 144 companies.

What are Parkwalk Advisors's most recent investments?

Recent Parkwalk Advisors portfolio additions include NoBACZ, Trismik, Enhanc3D Genomics, Xampla, Paragraf. These companies were founded in 2020 or later.

Explore Other Top Investors

Discover portfolio companies of other leading venture capital firms and investors.

View All Investors